BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30922343)

  • 1. Proposed revision of the 8th edition AJCC clinical staging system for esophageal squamous cell cancer treated with definitive chemo-IMRT based on CT imaging.
    Chen M; Li X; Chen Y; Liu P; Chen Z; Shen M; Liu X; Lin Y; Yang R; Ni W; Zhou X; Zhang L; Tian Y; Chen J; Fu L
    Radiat Oncol; 2019 Mar; 14(1):54. PubMed ID: 30922343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new clinical staging system for esophageal cancer to predict survival after definitive chemoradiation or radiotherapy.
    Chen J; Lin Y; Cai W; Su T; Wang B; Li J; Wu J; Pan J; Chen C
    Dis Esophagus; 2018 Nov; 31(11):. PubMed ID: 29961898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the 7th and 8th editions of the American Joint Committee on Cancer/Union for International Cancer Control TNM staging system for esophageal squamous cell carcinoma treated by definitive radiotherapy.
    Inada M; Nishimura Y; Ishikawa K; Nakamatsu K; Wada Y; Uehara T; Fukuda K; Anami S; Doi H; Kanamori S
    Esophagus; 2019 Oct; 16(4):371-376. PubMed ID: 31111308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.
    Nomura M; Shitara K; Kodaira T; Hatooka S; Mizota A; Kondoh C; Yokota T; Takahari D; Ura T; Muro K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):946-52. PubMed ID: 21362578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed revision of N categories to the 8th edition of the AJCC-TNM staging system for non-surgical esophageal squamous cell cancer.
    Hu K; Kang N; Liu Y; Guo D; Jing W; Lu J; Tan T; Lv C; Deng Y; Long J; Wang R; Yu J
    Cancer Sci; 2019 Feb; 110(2):717-725. PubMed ID: 30467921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement.
    Chung TR; Kim JH; Lee IJ; Cho Y; Kim JW; Lee CG; Jung DH; Park JJ; Youn YH; Park H
    Dig Liver Dis; 2019 Nov; 51(11):1610-1616. PubMed ID: 31175014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of the nodal status on the overall survival of non-surgical patients with esophageal squamous cell carcinoma.
    Zhao Z; Zhang Y; Wang P; Wang X; Li M
    Radiat Oncol; 2019 Sep; 14(1):161. PubMed ID: 31481064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
    Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of b-values in diffusion-weighted imaging for esophageal cancer: Measuring the longitudinal length of gross tumor volume and evaluating chemoradiotherapeutic efficacy.
    Liu G; Yang Z; Li T; Yang L; Zheng X; Cai L
    J Cancer Res Ther; 2017; 13(5):748-755. PubMed ID: 29237898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
    World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification.
    Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Kakeji Y
    Eur J Surg Oncol; 2022 Aug; 48(8):1760-1767. PubMed ID: 35094909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exploration of the classification of gross tumor volume and pathological staging of esophageal carcinoma].
    Xu Q; Zhu SC; Liu ZK; Cao YK; Song CL; Li YM; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):432-5. PubMed ID: 20819484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the 8
    van Gysen K; Stevens M; Guo L; Jayamanne D; Veivers D; Wignall A; Pang L; Guminski A; Lee A; Hruby G; Macleod P; Taylor A; Eade T
    BMC Cancer; 2019 Jul; 19(1):674. PubMed ID: 31288767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.
    Chen J; Su T; Lin Y; Wang B; Li J; Pan J; Chen C
    Clin Transl Oncol; 2018 Mar; 20(3):411-419. PubMed ID: 28779422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.
    Dyk P; Jiang N; Sun B; DeWees TA; Fowler KJ; Narra V; Garcia-Ramirez JL; Schwarz JK; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):794-801. PubMed ID: 25245584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation field size and dose determine oncologic outcome in esophageal cancer.
    Gemici C; Yaprak G; Batirel HF; Ilhan M; Mayadagli A
    World J Surg Oncol; 2016 Oct; 14(1):263. PubMed ID: 27737673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric staging in oropharyngeal cancer patients treated with definitive IMRT.
    Studer G; Glanzmann C
    Oral Oncol; 2013 Mar; 49(3):269-76. PubMed ID: 23089460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma.
    Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF
    Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship of gross tumor volume with lymph node metastasis and prognosis of esophageal carcinoma].
    Xu Q; Liu ZK; Cao YK; Li YM; Zhu SC
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):684-7. PubMed ID: 23159082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.